Tuberculosis
Study findings from C. Yang et al provide new insights into tuberculosis
Published in Vaccine Weekly, January 6th, 2010
In this recent study, researchers in Chongqing, People's Republic of China conducted a study "To study the effects and mechanisms of recombinant Mycobacterium smegmatis (rMS) carrying pZM03 (a co-expression plasmid encoding human granulysin [GLS] and murine interleukin 12 [IL-12]) on murine M. tuberculosis infection. BALB/c mice infected with M. tuberculosis were treated with normal saline, M. smegmatis, pZM03 or rMS."
"The number of viable bacteria in the lungs and spleens were counted to observe the therapeutic effects. The levels of IL-12 and interferon-gamma (IFN-gamma) in serum, and IFN-gamma and turnout necrosis factor-alpha (TNF-alpha) released from spleen...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-01-06)
More Articles from Vaccine Weekly
- Research
Studies generate hundreds of leads in the fight against the H1N1 pandemic - CSL Limited
Findings of Australian Trial of CSL's Pandemic H1N1 2009 'Swine' Flu Vaccine in Children Published in Journal of the American Medical Association JAMA - Fred Hutchinson Cancer Research Center
Aggressive Infection Control Program Protects Cancer Patients from Acquiring Clinic-Based H1N1 Influenza - Gene Therapy
Scientists at Ruhr University report research in gene therapy - H1N1 Virus
Findings from H. Xie and co-authors broaden understanding of h1n1 virus - Immunization
Research from L.J. Ledwich et al broadens understanding of immunization - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
